Imperial Innovations Group plc (AIM: IVO, 'Innovations', or 'the Group') a leading technology commercialisation and investment company, announces that its portfolio company, Autifony Therapeutics has initiated a Phase I clinical study of AUT00063, its ...

Imperial Innovations' portfolio company, Econic Technologies, announces that Rulande Henderson has joined as Commercial Director.

... Q2 8-Aug GB HENDERSON GROUP PLC INTERIM 8-Aug GR COCA COLA HELLENIC BOTTLING CO SA Q2 8-Aug DE HENKEL AG & CO KGAA Q2 8-Aug FI 12:00 HONKARAKENNE OYJ Q2 8-Aug IT BANCA IFIS SPA Q2 8-Aug DE INIT INNOVATION IN .... Q2 13-Aug DE HYPO REAL ESTATE ...

Professor in gastrointestinal epidemiology, Imperial College London. ... Group head, growth and livelihoods, Department for International Development.

Canadian Imperial Bank of Commerce, the country's fifth-largest bank, named Tom Woods vice chairman and promoted Laura Dottori-Attanasio to chief risk officer to replace Woods, according to Vlaad and Co.

Following financial backing from Pfizer Venture Investments, International Biotechnology Trust, SV Life Sciences, Imperial Innovations plc and UCL Business plc - the project now has a total of �15.75 million funding. Autifony Therapeutics, a ...

HSBA HSBC HOLDINGS PLC ORD $0.50 (UK REG) value of shares traded �57,703,419 RIO RIO TINTO PLC ORD 10P value of shares traded �36,596,663 VOD VODAFONE GROUP PLC ORD USD0.11 3/7 value of shares traded �36,301,608 BP. ... PLC ORD 28 101/108P value of ...

In the UK washing and bathing division, an ongoing programme of new product development has ensured that the core brands of Imperial Leather, Carex and Original Source have continued to perform well despite intense promotional activity in the trade and ...

AVEVA Group plc (LON: AVV) had its strong-buy rating reiterated by analysts at Goldman Sachs. They currently have a GBX 3,150 ($48.00) price target on the stock.

Entries were reviewed by a board of leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.